日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ziftomenib in Relapsed or Refractory NPM1-Mutated AML

Ziftomenib治疗复发或难治性NPM1突变型急性髓系白血病

Wang, Eunice S; Montesinos, Pau; Foran, James; Erba, Harry; Rodríguez-Arbolí, Eduardo; Fedorov, Kateryna; Heiblig, Maël; Heidel, Florian H; Altman, Jessica K; Baer, Maria R; Ades, Lionel; Pettit, Kristen; Peterlin, Pierre; Papayannidis, Cristina; Berthon, Céline; Walter, Roland B; Shah, Mithun V; Balasubramanian, Suresh; Khawandanah, Mohamad; Salamero Garcia, Olga; Bergeron, Julie; Madanat, Yazan F; Roboz, Gail J; Ulrickson, Matthew; Redner, Robert L; McCloskey, James; Pigneux, Arnaud; de la Fuente Burguera, Adolfo; Mitra, Amitava; Soifer, Harris S; Tabachri, Marilyn; Zhang, Zijing; Riches, Marcie; Corum, Daniel; Leoni, Mollie; Issa, Ghayas C; Fathi, Amir T

Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial

对60岁及以上新诊断急性髓系白血病患者进行分子特征分析:来自Beat AML临床试验的报告

Hoff, Fieke W; Huang, Ying; Welkie, Rina Li; Swords, Ronan T; Traer, Elie; Stein, Eytan M; Lin, Tara L; Patel, Prapti A; Collins, Robert H Jr; Baer, Maria R; Duong, Vu H; Blum, William G; Arellano, Martha L; Stock, Wendy; Odenike, Olatoyosi; Redner, Robert L; Kovacsovics, Tibor; Deininger, Michael W; Zeidner, Joshua F; Olin, Rebecca L; Smith, Catherine C; Foran, James M; Schiller, Gary J; Curran, Emily K; Koenig, Kristin L; Heerema, Nyla A; Chen, Timothy; Martycz, Molly; Stefanos, Mona; Marcus, Sonja G; Rosenberg, Leonard; Druker, Brian J; Levine, Ross L; Burd, Amy; Yocum, Ashley O; Borate, Uma M; Mims, Alice S; Byrd, John C; Madanat, Yazan F

Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients

一项针对老年急性髓系白血病患者的二期临床研究,评估了地西他滨联合阿糖胞苷进行表观遗传启动治疗的疗效。

Im, Annie; Quann, Kevin; Agha, Mounzer; Raptis, Anastasios; Redner, Robert L; Hou, Jing-Zhou; Farah, Rafic; Dorritie, Kathleen A; Sehgal, Alison R; Normolle, Daniel; Bovbjerg, Dana H; Aggarwal, Nidhi; Herman, James; Lontos, Konstantinos; Boyiadzis, Michael

A phase II study of post-remission therapy with pembrolizumab in older patients with acute myeloid leukemia

一项针对老年急性髓系白血病患者缓解后使用帕博利珠单抗进行治疗的II期研究

Quann, Kevin; Lontos, Konstantinos; Sehgal, Alison; Raptis, Anastasios; Im, Annie; Redner, Robert L; Dorritie, Kathleen A; Agha, Mounzer; Hou, Jing-Zhou; Farah, Rafic; Rossetti, James; Normolle, Daniel P; Whiteside, Theresa L; Hsu, Yen-Michael Sheng; Boyiadzis, Michael

Beat-AML 2024 ELN-refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy

Beat-AML 2024 ELN 针对接受低强度治疗的新诊断 AML 老年患者进行了风险分层优化

Hoff, Fieke W; Blum, William G; Huang, Ying; Welkie, Rina Li; Swords, Ronan T; Traer, Elie; Stein, Eytan M; Lin, Tara L; Archer, Kellie J; Patel, Prapti A; Collins, Robert H; Baer, Maria R; Duong, Vu H; Arellano, Martha L; Stock, Wendy; Odenike, Olatoyosi; Redner, Robert L; Kovacsovics, Tibor; Deininger, Michael W; Zeidner, Joshua F; Olin, Rebecca L; Smith, Catherine C; Foran, James M; Schiller, Gary J; Curran, Emily K; Koenig, Kristin L; Heerema, Nyla A; Chen, Timothy; Martycz, Molly; Stefanos, Mona; Marcus, Sonja G; Rosenberg, Leonard; Druker, Brian J; Levine, Ross L; Burd, Amy; Yocum, Ashley O; Borate, Uma M; Mims, Alice S; Byrd, John C; Madanat, Yazan F

Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial

Entospletinib联合地西他滨治疗TP53突变或复杂核型急性髓系白血病:Beat AML Master试验的II期子研究

Duong, Vu H; Ruppert, Amy S; Mims, Alice S; Borate, Uma; Stein, Eytan M; Baer, Maria R; Stock, Wendy; Kovacsovics, Tibor; Blum, William; Arellano, Martha L; Schiller, Gary J; Olin, Rebecca L; Foran, James M; Litzow, Mark R; Lin, Tara L; Patel, Prapti A; Foster, Matthew C; Redner, Robert L; Al-Mansour, Zeina; Cogle, Christopher R; Swords, Ronan T; Collins, Robert H; Vergilio, Jo-Anne; Heerema, Nyla A; Rosenberg, Leonard; Yocum, Ashley O; Marcus, Sonja; Chen, Timothy; Druggan, Franchesca; Stefanos, Mona; Gana, Theophilus J; Shoben, Abigail B; Druker, Brian J; Burd, Amy; Byrd, John C; Levine, Ross L; Boyiadzis, Michael M

Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy

首次诱导后骨髓活检中原始细胞免疫表型的预后意义

Lontos, Konstantinos; Tsagianni, Anastasia; Agha, Mounzer; Raptis, Anastasios; Hou, Jing-Zhou; Farah, Rafic; Redner, Robert L; Im, Annie; Dorritie, Kathleen A; Sehgal, Alison; Rossetti, James; Aggarwal, Nidhi; Saul, Melissa; Boyiadzis, Michael; Bailey, Nathanael G

A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML

利用细胞遗传学、TP53 和 NPM1 突变状态构建的列线图可以预测急性髓系白血病 (AML) 对诱导化疗的反应。

Lontos, Konstantinos; Tsagianni, Anastasia; Agha, Mounzer; Raptis, Anastasios; Hou, Jing-Zhou; Farah, Rafic; Redner, Robert L; Im, Annie; Dorritie, Kathleen A; Sehgal, Alison; Rossetti, James; Aggarwal, Nidhi; Saul, Melissa; Gooding, William; Boyiadzis, Michael

The eyes have it: CNS leukemia presenting as optic neuritis

眼睛会发病:中枢神经系统白血病表现为视神经炎

Quann, Kevin A; Redner, Robert L

A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia

达沙替尼联合全反式维甲酸治疗急性髓系白血病的1期研究

Redner, Robert L; Beumer, Jan H; Kropf, Patricia; Agha, Mounzer; Boyiadzis, Michael; Dorritie, Kathleen; Farah, Rafic; Hou, Jing-Zhao; Im, Annie; Lim, Seah H; Raptis, Anastasios; Sehgal, Alison; Christner, Susan M; Normolle, Daniel; Johnson, Daniel E